NextCure, Inc.
NXTCDrugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Next month
Market Overview
Stock performance and key metrics
1 upcoming, 0 past
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in NextCure, Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in NextCure, Inc.'s (NXTC) pipeline across Phase 2. Its lead program is NC318 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is NextCure, Inc.'s next FDA catalyst?→
NextCure, Inc.'s (NXTC) next tracked catalyst is a Earnings expected November 4, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track NXTC biotech catalysts?→
Add NXTC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow NextCure, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.